Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is $997.5, with a 24-hour trading volume of $1.03B. The asset's market cap is $890.75B, after moving -0.19% in the last day.
Tokenized Eli Lilly And Co is trading at $999.42, with a tokenized market cap of $5.5M and a 24-hour trading volume of $2.38M. The tokenized asset has moved -0.05% in the past 24 hours.